• Perspectum Completes $55M Series C to Improve Metabolic Disease Diagnosis

    8 days ago - By MedCity News

    Perspectum - a company that makes medical imaging devices designed to improve the diagnosis of metabolic diseases and cancer - recently announced the second close of its $55 million Series C funding round. Its flagship product is a diagnostic tool that assesses and monitors chronic liver disease.
    Read more ...